Rosuvastatin Calcium CAS 147098-20-2 Assay 98.5%~102.0% API Factory High Purity
Supply with High Purity and Stable Quality
Rosuvastatin Calcium
CAS: 147098-20-2
Commercial Production
Chemical Name | Rosuvastatin Calcium |
Mashoko anoreva zvakafanana | ZD 4522 Calcium;(E) -6--[4-(4-Fluorophenyl)-6-Isopropyl-2-(Methyl-Methylsulfonyl-amino)pyrimidin-5-yl]-2,4-Dihydroxy-hex-5-Enoate;(6E)-7-{4-(4-Fluorophenyl)-6-(1-Methylethyl)-2-[Methyl(methylsulfonyl) amino]pyrimidin-5-yl}-3,5-Dihydroxyhept-6-Enoic Acid |
Nhamba yeCAS | 147098-20-2 |
Stock Status | MuStock, Kugadzirwa Kunokwira Kusvika Matani |
Molecular Formula | C44H54CaF2N6O12S2 |
Molecular Weight | 1001.14 |
Melting Point | 122℃ |
Shipping Condition | Yakatumirwa Pasi peAmbient Temperature |
Brand | Ruifu Chemical |
Item | Zvinotsanangurwa |
Chitarisiko | Ichena kusvika kuOff-White Powder |
Specific Rotation | +17.0° ~ +21.0° |
Identification | A. Zvinozadzisa Zvinodiwa B. UV: λmax=243nm C. IR: Zvakafanana neReference Substance D. X-Ray: Yakafanana neReference Substance |
Chloride | ≤0.10% |
Sulfate | ≤0.10% |
Enantiomer | ≤0.15% |
Calcium Content | 3.5%~4.5% |
Related Substances | |
Diastereomer | ≤0.15% |
5-Oxo-Rosucastatin | ≤0.15% |
Kushatisa Mufananidzo 1 | ≤0.15% |
Kushatisa Mufananidzo 2 | ≤0.15% |
Rosuvastatin Lactone | ≤0.15% |
Rosuvastatin Methyl Ester | ≤0.15% |
Rosuvastatin Isoamyl Ester | ≤0.15% |
Chero Kusachena Kusingazivikanwe | ≤0.10% |
Zvose Zvisina Kuchena | ≤0.75% |
Kunyorova (KF) | ≤3.0% |
Simbi inorema | ≤20ppm |
Isoamyl Bromide | ≤37.5ppm |
Residual Solvents | |
Ethyl Ether | ≤300ppm |
Acetonitrile | ≤410ppm |
Isoamyl Doro | ≤5000ppm |
DMF | ≤880ppm |
Assay | 98.5% ~ 102.0% (yakaverengerwa pane anhydrous basis) |
Test Standard | Enterprise Standard;BP/USP/EP Standard |
Usage | API |
Package: Bhodhoro, Bhodhoro, Kadhibhodhi dhiramu, 25kg/Barel, kana zvinoenderana nezvinodiwa nemutengi.
Storage Condition:Chengetedza mumidziyo yakavharwa panzvimbo inotonhorera uye yakaoma;Dzivirira kubva kuchiedza, unyoro
Rosuvastatin Calcium (CAS: 147098-20-2) mushonga unorwisa-hyperlipidemia uri weiyo inhibitor yeHMG-CoA reductase yakabudirira kugadzirwa neBritish AstraZeneca kambani.Inokodzera kurapwa kweakasiyana lipid abnormalities, kusanganisira hypercholesterolemia, yakasanganiswa lipid qualitative abnormalities uye nyore hypertriglyceridemia.Rosuvastatin Calcium (CAS: 147098-20-2) yakanyorwa seyakasimba uye yakazara statins mishonga yakapinda mumusika welipid-kudzikisa uye kugadzirisa.Kuenzaniswa ne atorvastatin iyo parizvino inozivikanwa neiyo nyika inoshanda zvakanyanya, ine mhedzisiro iri nani yekudzikisa mwero weLDL cholesterol uye kuwedzera mwero we-high-density lipoprotein.Uyezve, ine kushivirira kuri nani, yakaderera mhedzisiro uye yakasarudzika pharmacokinetic hunhu nehafu yehupenyu inenge 20h.